Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China · Delayed Price · Currency is CNY 11.83
+0.49 (4.32%)
Sep 30, 2026, 3:04 PM CST
SHE:002020 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 485.33 | 530.71 | 316.27 | 1,461 | 1,548 | 1,561 |
Short-Term Investments | 1,090 | - | - | - | - | - |
Trading Asset Securities | 632.08 | 318.96 | 827.66 | 150.96 | 366.89 | 422.4 |
Cash & Short-Term Investments | 2,207 | 849.67 | 1,144 | 1,612 | 1,915 | 1,983 |
Cash Growth | 303.23% | -25.72% | -29.03% | -15.85% | -3.41% | -8.38% |
Accounts Receivable | 756.56 | 881.12 | 852.02 | 612.58 | 509.57 | 510.67 |
Other Receivables | 89.04 | 40.46 | 55.26 | 51.44 | 59.13 | 103.81 |
Receivables | 845.61 | 921.58 | 907.27 | 664.02 | 568.7 | 614.47 |
Inventory | 799.56 | 766.15 | 792.72 | 652.69 | 773.7 | 677.69 |
Prepaid Expenses | 0.8 | 3.22 | 3.36 | 3.7 | 2.52 | 0.81 |
Other Current Assets | 40.57 | 760.19 | 57.5 | 421.56 | 20.88 | 17.82 |
Total Current Assets | 3,894 | 3,301 | 2,905 | 3,354 | 3,281 | 3,294 |
Property, Plant & Equipment | 2,196 | 2,281 | 2,188 | 2,300 | 1,632 | 1,297 |
Long-Term Investments | 840.95 | 1,488 | 2,161 | 1,124 | 1,134 | 882.21 |
Goodwill | 315.71 | 335.6 | 348.48 | 348.48 | 348.48 | 348.48 |
Other Intangible Assets | 426.64 | 431.89 | 382.26 | 401.26 | 418.59 | 157 |
Long-Term Deferred Tax Assets | 75.6 | 79.23 | 83.56 | 80.98 | 75.11 | 68.64 |
Long-Term Deferred Charges | 33.91 | 38.93 | 58.73 | 21.2 | 26.71 | 55.95 |
Other Long-Term Assets | 169.94 | 167.59 | 351.9 | 356.72 | 446.73 | 443.95 |
Total Assets | 7,953 | 8,124 | 8,479 | 7,987 | 7,363 | 6,547 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 577.41 | 666.34 | 880.79 | 941.16 | 719.12 | 449.79 |
Accrued Expenses | 175.57 | 225.72 | 198.28 | 206.39 | 187.72 | 189.47 |
Short-Term Debt | 169.49 | 284.39 | 281.36 | 279.09 | 238.58 | 148.33 |
Current Portion of Long-Term Debt | - | - | - | - | 0.05 | 0.27 |
Current Portion of Leases | 13.01 | 6.63 | 13.3 | 11.86 | 14.69 | 14.66 |
Current Income Taxes Payable | 33 | 41.65 | 89.18 | 44.3 | 59.99 | 50.25 |
Current Unearned Revenue | 42.87 | 56.45 | 56.48 | 53.35 | 81.01 | 47.61 |
Other Current Liabilities | 557.52 | 625.72 | 615.12 | 538.61 | 514.23 | 521.88 |
Total Current Liabilities | 1,569 | 1,907 | 2,135 | 2,075 | 1,815 | 1,422 |
Long-Term Debt | - | - | - | - | - | 0.04 |
Long-Term Leases | 27.8 | 22.63 | 23.13 | 31.23 | 42.98 | 30.62 |
Long-Term Unearned Revenue | 263.71 | 263.91 | 264.59 | 268.81 | 270.6 | 128.73 |
Long-Term Deferred Tax Liabilities | 52.84 | 58.96 | 54.33 | 68.4 | 59.68 | 65.44 |
Other Long-Term Liabilities | 1.07 | 0.86 | 1.19 | 3.2 | 1.94 | 0.74 |
Total Liabilities | 1,914 | 2,253 | 2,478 | 2,446 | 2,191 | 1,648 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 861.03 | 861.03 | 861.03 | 861.03 | 861.03 | 905.32 |
Additional Paid-In Capital | 1,732 | 1,723 | 1,723 | 1,723 | 1,720 | 2,236 |
Retained Earnings | 3,905 | 3,841 | 3,368 | 2,914 | 2,554 | 2,150 |
Treasury Stock | -517.04 | -608.78 | - | - | - | -437.62 |
Comprehensive Income & Other | 18.95 | 16.65 | 17.17 | 13.86 | 11.31 | 8.05 |
Total Common Equity | 6,000 | 5,833 | 5,970 | 5,512 | 5,146 | 4,862 |
Minority Interest | 38.07 | 37.23 | 32.04 | 27.78 | 25.85 | 37.72 |
Shareholders' Equity | 6,038 | 5,870 | 6,002 | 5,540 | 5,172 | 4,899 |
Total Liabilities & Equity | 7,953 | 8,124 | 8,479 | 7,987 | 7,363 | 6,547 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 210.3 | 313.65 | 317.79 | 322.18 | 296.3 | 193.92 |
Net Cash (Debt) | 1,997 | 536.02 | 826.13 | 1,290 | 1,619 | 1,789 |
Net Cash Growth | 770.63% | -35.12% | -35.94% | -20.35% | -9.51% | -4.00% |
Net Cash Per Share | 2.46 | 0.65 | 0.96 | 1.50 | 1.88 | 2.19 |
Filing Date Shares Outstanding | 820.88 | 813.76 | 861.03 | 861.03 | 861.03 | 861.03 |
Total Common Shares Outstanding | 820.88 | 813.76 | 861.03 | 861.03 | 861.03 | 861.03 |
Working Capital | 2,325 | 1,394 | 770.26 | 1,279 | 1,466 | 1,872 |
Book Value Per Share | 7.31 | 7.17 | 6.93 | 6.40 | 5.98 | 5.65 |
Tangible Book Value | 5,258 | 5,066 | 5,239 | 4,763 | 4,379 | 4,356 |
Tangible Book Value Per Share | 6.41 | 6.22 | 6.08 | 5.53 | 5.09 | 5.06 |
Land | - | - | - | -0.21 | - | - |
Buildings | 1,729 | 1,797 | 1,629 | 1,388 | 934.82 | 889.16 |
Machinery | 1,903 | 1,840 | 1,754 | 1,412 | 1,219 | 946.45 |
Construction In Progress | 44.41 | 52.71 | 13.62 | 482.06 | 284.91 | 161.34 |